Alcohol Use Disorder Treatment Market Size, Share, Opportunities, And Trends By Type (Alcohol Abuse, Alcoholism (Alcohol dependence)), By Treatment (Medication, Behavioural Therapy), And Geography - Forecasts From 2025 To 2030

Alcohol Use Disorder Treatment Market Size:

The Alcohol Use Disorder Treatment Market is expected to grow from US$5,949.402 million in 2025 to US$7,794.812 million in 2030, at a CAGR of 5.55%.

The growing demand for the alcohol use disorder treatment is mainly attributed to the prevalence of this disease worldwide, with the high prevalence reported in Eastern European countries, parts of South East Asia and selected countries in Americas. According to the estimates by the Institute of Medicine, in 1996 the prevalence of Fetal Alcohol Syndrome (FAS) in the United States was between 0.5 and 3.0 cases per 1,000. As per the recent reports from the specific U.S. sites, the prevalence of FAS was found to be 2 to 7 cases per 1,000, and the prevalence of Fetal Alcohol Spectrum Disorders (FASD) was estimated to be as high as 20 to 50 cases per 1,000 (Source: National Institutes of Health). Furthermore, the rising number of deaths occurring due to alcohol-related liver disease is driving the market growth during the forecast period.

 

Major industry players profiled as part of the report are Teva Pharmaceuticals USA, Inc., Adial Pharmaceuticals, Alkermes, ADDEX THERAPEUTICS, Kinnov Therapeutics, OPIANT PHARMACEUTICALS, INC, Ethypharm, and MONTISERA LTD.

Alcohol Use Disorder Treatment Market Scope:

Report Metric	Details
Alcohol Use Disorder Treatment Market Size in 2025	US$5,949.402 million
Alcohol Use Disorder Treatment Market Size in 2030	US$7,794.812 million
Growth Rate	CAGR of 5.55%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Million
Segmentation	Type Treatment Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Alcohol Use Disorder Treatment Market	Teva Pharmaceuticals USA, Inc. Adial Pharmaceuticals Alkermes ADDEX THERAPEUTICS Kinnov Therapeutics
Customization Scope	Free report customization with purchase

 

 

 

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Currency

1.5. Assumptions

1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY 

2.1. Research Design

2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Overview and Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Prevalence

4.5.1. By age group

4.5.2. By gender

4.5.3. By region

4.6. Product Pipeline

4.7. Innovations

5. ALCOHOL USE DISORDER TREATMENT MARKET BY TYPE

5.1. Alcohol Abuse

5.2. Alcoholism (Alcohol dependence)

6. ALCOHOL USE DISORDER TREATMENT MARKET BY TREATMENT

6.1. Medication

6.2. Behavioural Therapy

7. ALCOHOL USE DISORDER TREATMENT MARKET BY GEOGRAPHY

7.1. North America

7.1.1. USA

7.1.2. Canada

7.1.3. Mexico

7.2. South America

7.2.1. Brazil

7.2.2. Argentina

7.2.3. Others

7.3. Europe

7.3.1. Germany

7.3.2. France

7.3.3. United Kingdom

7.3.4. Spain

7.3.5. Others

7.4. Middle East and Africa

7.4.1. Saudi Arabia

7.4.2. Israel

7.4.3. Others

7.5. Asia Pacific

7.5.1. China

7.5.2. Japan

7.5.3. South Korea

7.5.4. India

7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1.  Competitive Benchmarking and Analysis

8.2.  Recent Investments and Deals

8.3. Strategies of Key Players

9. COMPANY PROFILES

9.1. Teva Pharmaceuticals USA, Inc.

9.2. Adial Pharmaceuticals

9.3. Alkermes

9.4. ADDEX THERAPEUTICS

9.5. Kinnov Therapeutics

9.6. OPIANT PHARMACEUTICALS, INC

9.7. Ethypharm

9.8. MONTISERA LTD

LIST OF FIGURES

LIST OF TABLES

Teva Pharmaceuticals USA, Inc.

Adial Pharmaceuticals

Alkermes

ADDEX THERAPEUTICS

Kinnov Therapeutics

OPIANT PHARMACEUTICALS, INC

Ethypharm

MONTISERA LTD